查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728150

關節痛注射市場－全球產業規模、佔有率、趨勢、機會和預測（按注射類型、應用、地區和競爭細分，2020-2030 年）

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection, By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球關節痛注射市場價值為 46.6 億美元，預計將出現強勁成長，到 2030 年達到巨大的市場潛力，複合年成長率為 7.02%。這個市場領域迎合了全球性內骨關節炎和類風濕性關節炎等關節相關疾病發生率不斷上升的需求。關節疼痛注射為治療慢性關節疼痛和發炎提供了一種微創且有效的手術替代方法。這些治療包括皮質類固醇、透明質酸、富血小板血漿 (PRP) 和胎盤組織基質注射，旨在減輕疼痛、改善活動能力並增強整體關節功能。全球人口老化和對非手術治療方案的需求不斷增加正在加速市場擴張。

市場概覽
預測期 2026-2030
2024年市場規模 46.6億美元
2030年市場規模 69.5億美元
2025-2030 年複合年成長率 7.02%
成長最快的領域 玻尿酸注射
最大的市場 北美洲

關鍵市場促進因素

肥胖率上升

主要市場挑戰

報銷問題

主要市場趨勢

生物製劑和再生療法的進展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球關節痛注射市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依注射類型（類固醇關節注射、透明質酸注射、富血小板血漿 (PRP) 注射、胎盤組織基質 (PTM) 注射、其他）
    • 依應用（肩關節和肘關節、膝關節和踝關節、脊椎關節、髖關節、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按注射類型
    • 按應用
    • 按地區

第6章：北美關節痛注射市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲關節痛注射劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章：亞太地區關節痛注射市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章：南美關節痛注射市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲關節痛注射市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20639

The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.66 Billion
Market Size 2030USD 6.95 Billion
CAGR 2025-20307.02%
Fastest Growing SegmentHyaluronic Acid Injections
Largest MarketNorth America

Key Market Drivers

Rising Obesity Rates

The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.

Key Market Challenges

Reimbursement Issues

Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.

Key Market Trends

Advancements in Biologics and Regenerative Therapies

Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.

Key Market Players

  • Anika Therapeutics Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals Inc
  • Sanofi SA
  • Pfizer Inc
  • Eli Lilly & Co
  • Flexion Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holdings, Inc.

Report Scope:

In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Joint Pain Injections Market, By Type of Injection:

  • Steroid Joint Injections
  • Hyaluronic Acid Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Others

Joint Pain Injections Market, By Application:

  • Shoulder & Elbow
  • Knee & Ankle
  • Spinal Joints
  • Hip Joint
  • Others

Joint Pain Injections Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.

Available Customizations:

Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Joint Pain Injections Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type of Injection
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Joint Pain Injections Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Joint Pain Injections Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Injection
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Joint Pain Injections Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Injection
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Joint Pain Injections Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Injection
        • 6.3.3.2.2. By Application

7. Europe Joint Pain Injections Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Joint Pain Injections Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Injection
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Joint Pain Injections Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Injection
        • 7.3.2.2.2. By Application
    • 7.3.3. France Joint Pain Injections Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Injection
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Joint Pain Injections Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Injection
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Joint Pain Injections Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Injection
        • 7.3.5.2.2. By Application

8. Asia-Pacific Joint Pain Injections Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Joint Pain Injections Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Injection
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Joint Pain Injections Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Injection
        • 8.3.2.2.2. By Application
    • 8.3.3. India Joint Pain Injections Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Injection
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Joint Pain Injections Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Injection
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Joint Pain Injections Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Injection
        • 8.3.5.2.2. By Application

9. South America Joint Pain Injections Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Joint Pain Injections Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Injection
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Joint Pain Injections Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Injection
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Joint Pain Injections Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Injection
        • 9.3.3.2.2. By Application

10. Middle East and Africa Joint Pain Injections Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
    • 10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Joint Pain Injections Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Injection
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Injection
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Joint Pain Injections Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Injection
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Joint Pain Injections Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type of Injection
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Anika Therapeutics Inc
  • 14.2. Bioventus LLC
  • 14.3. Ferring Pharmaceuticals Inc
  • 14.4. Sanofi SA
  • 14.5. Pfizer Inc
  • 14.6. Eli Lilly & Co
  • 14.7. Flexion Therapeutics Inc
  • 14.8. Teva Pharmaceutical Industries Ltd
  • 14.9. Zimmer Biomet Holdings, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer